Clinical Results for an Active Surveillance Cohort with Localized Prostate Cancer Receiving RT after Exiting Active Surveillance

Active surveillance (AS) may reduce overtreatment of clinically insignificant prostate cancer (PCa) while keeping the option of definitive therapy for those patients (pts) reclassified over time as higher risk. We performed a prospective clinical trial to evaluate AS: our entire AS cohort was previously reported, we here present clinical outcome for the sub-cohort who received RT at our institution after AS discontinuation. Eligibility criteria...